Clinical Trials Directory

Trials / Completed

CompletedNCT02861079

Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study

Compare Prostaglandin E2 Against to Combined Use of Transcervical Foley Catheter Balloon With Vaginal Prostaglandin E2 for Induction of Labor at Term: A Randomized Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study evaluates the addition of transcervical Foley catheter balloon and vaginal prostaglandin E2 in induction of labor at term. Half of participants will be used combine transcervical Foley catheter balloon and vaginal prostaglandin E2, while the other half will be used alone vaginal prostaglandin E2.

Detailed description

An unfavorable cervix during induction decreases the success rate of labor induction and vaginal delivery. Therefore it is required to apply cervical ripening methods for unfavorable cervices. Application of transcervical Foley catheter is an effective mechanical method and has the advantages of lower cost and lowest rate of fetal heart rate changes due to tachysystole compared with PGE1 and PGE2. Despite the advantages of mechanical methods, PGE1 and PGE2 are reported to be more effective than mechanical methods to achieve vaginal delivery within 24 hours. Although there are a lot of studies comparing PGE1, PGE2 and transcervical Foley balloon catheter separately and PGE1 combined with transcervical Foley balloon catheter, less is known about combined usage of PGE2 and transcervical Foley balloon catheter.

Conditions

Interventions

TypeNameDescription
DEVICEFoley catheterAn 18-F Foley catheter will insert into the endocervical canal and the balloon will fill with 30 mL of saline solution.
DRUGPGE210 mg PGE2 vaginal ovul (Propess,Ferring®) will place high into the posterior vaginal fornix.

Timeline

Start date
2017-08-25
Primary completion
2017-12-25
Completion
2017-12-25
First posted
2016-08-10
Last updated
2018-02-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02861079. Inclusion in this directory is not an endorsement.